Comparative Effectiveness of Dexamethasone Versus Prednisone in Children Hospitalized With Acute Croup

Wen Jiang1,2, Matt Hall3, Jay G Berry4

  • 1Department of Otolaryngology, University of California San Diego, San Diego, California.

Hospital Pediatrics
|September 15, 2022
PubMed

Insights

Dexamethasone and prednisone/prednisolone showed similar hospital resource use for acute croup in children. Both corticosteroids are viable treatment options for hospitalized pediatric patients with croup.

Area of Science:

  • Pediatric Medicine
  • Pharmacology
  • Health Services Research

Background:

  • Acute croup is a common respiratory illness in young children.
  • Corticosteroids like dexamethasone and prednisone/prednisolone are used to treat croup.
  • Understanding their comparative effectiveness on hospital resource utilization is important for clinical practice and resource management.

Purpose of the Study:

  • To compare the effectiveness of dexamethasone versus prednisone or prednisolone on hospital resource utilization in children hospitalized with acute croup.

Main Methods:

  • Retrospective cohort study using the Pediatric Health Information System database (2015-2019).
  • Included children aged 6 months to <6 years hospitalized with acute croup.
  • Propensity score matching was used to compare length of stay, ICU transfer, bronchoscopy, 7-day ED returns, and readmissions.

Main Results:

  • No significant difference in length of stay or bronchoscopy rates between dexamethasone and prednisone/prednisolone groups.
  • Dexamethasone group showed a higher likelihood of ICU transfer (P = .007).
  • Rates of 7-day ED returns and readmissions were low and not statistically different between groups.

Conclusions:

  • Hospital resource utilization did not significantly differ between dexamethasone and prednisone/prednisolone for acute croup.
  • Both corticosteroids are considered reasonable treatment choices for hospitalized children with acute croup.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
366
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
282
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
192
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
397
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
412